Pidilizumab

REQUEST MORE INFO
Catalogue No: abx831270
Price: US$464.00
(Size: 100 µg)

Orders to United States ship from United States

Reviews: 0 Publications and Reviews
(0 Publications and Reviews)
Pidilizumab

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Pidilizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).

Target PDCD1/CD279
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA, WB
Host Human
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG1 Kappa
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Buffer 0.01 M PBS. pH 7.4.
CAS Number 1036730-42-3
Concentration Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability Shipped within 7-12 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on PDCD1/CD279


Write a review

Continue
Tags:
(Click to show)